Pathway incompatibility between NF-kappaB and RAS signaling constrains oncogenicity in B-cell leukemia. Stewart E, Collins A, Kovacic B, Knupke M, et al. J Biol Chem 2026 Sep 8:113537. doi: 10.1016/j.jbc.2026.113537.

Read + Share

Amedeo Smart

Independent Medical Education

Stewart E, Collins A, Kovacic B, Knupke M, et al. Pathway incompatibility between NF-kappaB and RAS signaling constrains oncogenicity in B-cell leukemia. J Biol Chem 2026 Sep 8:113537. doi: 10.1016/j.jbc.2026.113537.
PMID: 42710672